Literature DB >> 7448111

An improved extraction procedure for the liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.

P Gyselinck, J P Remon, R Van Severen, P Braeckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448111      PMCID: PMC1430084          DOI: 10.1111/j.1365-2125.1980.tb01779.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Short excitation wavelength fluorometric detection in high-pressure liquid chromatography of indole peptide, naphthyl, and phenol compounds.

Authors:  G J Krol; C A Mannan; R E Pickering; D V Amato; B T Kho; A Sonnenschein
Journal:  Anal Chem       Date:  1977-10       Impact factor: 6.986

2.  Improved liquid-chromatographic determination of propranolol in plasma, with fluorescence detection.

Authors:  P Jatlow; W Bush; H Hochster
Journal:  Clin Chem       Date:  1979-05       Impact factor: 8.327

3.  Sensitive high-pressure liquid chromatographic determination of propranolol in plasma.

Authors:  G Nygard; W H Shelver; S K Wahba Khalil
Journal:  J Pharm Sci       Date:  1979-03       Impact factor: 3.534

4.  Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography.

Authors:  A M Taburet; A A Taylor; J R Mitchell; D E Rollins; J L Pool
Journal:  Life Sci       Date:  1979-01-15       Impact factor: 5.037

5.  High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.

Authors:  R L Nation; G W Peng; W L Chiou
Journal:  J Chromatogr       Date:  1978-05-01

6.  Direct measurement of propranolol bioavailability during accumulation to steady-state.

Authors:  A J Wood; K Carr; R E Vestal; S Belcher; G R Wilkinson; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

  6 in total
  2 in total

1.  Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.

Authors:  D M Hibbard; J R Peters; D B Hunninghake
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

2.  Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.

Authors:  E Perucca; R Grimaldi; G Gatti; M Caravaggi; F Crema; S Lecchini; G M Frigo
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.